Sign up for news & promotions:
CAR-TCR Summit 2019
August 21, 2019
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
November 19, 2019
Initially Launching a Novel, High-Affinity BCMA CAR Targeting NK Cell Development Candidate For Multiple Myeloma, With An Option For Up To Five Additional CAR Targeting Sequences.
ProMab and NantKwest recently launched a collaboration to develop BCMA CAR-NK cell development.
Share